Update on COVID-19 Projections - Science Advisory and Modelling Consensus Tables February 1, 2022

Page created by Reginald Hale
 
CONTINUE READING
Update on COVID-19 Projections - Science Advisory and Modelling Consensus Tables February 1, 2022
Update on COVID-19 Projections
  Science Advisory and Modelling Consensus Tables
                  February 1, 2022
Update on COVID-19 Projections - Science Advisory and Modelling Consensus Tables February 1, 2022
Key findings
• It is challenging to model the spread of COVID-19 because of changes
  in testing, but other indicators suggest this phase of the Omicron wave
  has plateaued or is in decline.
• Public health measures helped control this phase. Relaxation of these
  measures will increase the spread of COVID-19. The size of any
  resurgence is difficult to predict and will depend on vaccination, the
  spread of Omicron, and changes in behaviour (e.g., mobility, masking).
• Surveillance will be important to detect changes in the trajectory of the
  pandemic.
• Hospitals are now caring for the highest number of people with COVID-
  19. Admissions are at highest levels across all age groups. ICU
  occupancy continues to be high. Staffing in hospitals remains critical.
• Ontario data shows that vaccination (including third doses) provides
  strong protection against serious illness. Increasing vaccine uptake
  across all groups will reduce the impact of the pandemic.
                                                                              2
Ontario’s COVID-19 wastewater signal peaked around Jan 4, 2022,
which would correspond to a peak in cases around Jan 11, 2022.
• Ontario’s COVID-19 wastewater                                                                   2.0
  signal is a population-weighted mean

                                           Standardized Concentration of SARS-CoV-2 Gene Copies
  of concentrations of SARS-CoV-2
  gene copies across 99 wastewater
  treatment plants, pumping stations                                                              1.5

  and sewersheds in all 34 public
  health units.
                                                                                                  1.0

• Taking into account the time lag until
  diagnosis and reporting, the peak of
  Ontario’s wastewater signal around                                                              0.5
  Jan 4, 2022 would correspond to a
  peak in cases around Jan 11, 2022.
• Plausible range of SARS-CoV-2                                                                   0.0

  infections that have occurred since

                                                                                                                                   1

                                                                                                                                               1

                                                                                                                                                            1
                                                                                                21

                                                                                                                      21

                                                                                                                                                                         22

                                                                                                                                                                                      22

                                                                                                                                                                                                    22

                                                                                                                                                                                                                 22
                                                                                                                                 -2

                                                                                                                                             -2

                                                                                                                                                          -2

                                                                                                                                                                       n-
                                                                                             c-

                                                                                                                   c-

                                                                                                                                                                                    n-

                                                                                                                                                                                                  n-

                                                                                                                                                                                                               n-
                                                                                                                               ec

                                                                                                                                           ec

                                                                                                                                                        ec
                                                                                          De

                                                                                                                De

                                                                                                                                                                     Ja

                                                                                                                                                                                - Ja

                                                                                                                                                                                              - Ja

                                                                                                                                                                                                           - Ja
                                                                                                                             -D

                                                                                                                                         -D

                                                                                                                                                      -D

                                                                                                                                                                  5-
  Dec 1, 2021 based on wastewater
                                                                                       1-

                                                                                                             8-

                                                                                                                                                                              12

                                                                                                                                                                                            19

                                                                                                                                                                                                         26
                                                                                                                           15

                                                                                                                                       22

                                                                                                                                                    29
                                                                                                                                                     Sampling Date
  signal: 1.5 to 4 million infections
                                                                                                  Data: Wastewater Dashboard hosted by Ontario’s Ministry of the Environment, Conservation and Parks (MECP)           3
                                                                                                        Analysis: Secretariat of the Science Advisory Table (https://covid19-sciencetable.ca/ontario-dashboard/)
Provincial % test positivity and testing volumes
                                                          Nov. 28                 Dec. 19        Dec. 31      Jan. 5
                                                          First Ontario   New public health    Changes to     Additional public
                                                          Omicron case          restrictions   PCR testing    health measures and
                                                          reported            implemented          criteria   shift to online school

                                                                                                                                       4
Data source: Public Health Ontario. PDNOC lab reporting
Positivity in selected populations is also declining.

Workplace screening                                                                                                                                  Repeat Testers                                                                   Hospital Admission Screening
(Workplace rapid screening program across                                                                                                            (Individuals with 40+ tests since pandemic start,                                (Selected Ontario hospitals, 4 for adult
Canada, twice per week, Ontario data shown)                                                                                                          20-79 years of age, excluding LTC residents)                                     admissions, 5 for pediatric admissions)

                                                        3.0%                                                                                         14%                                                                              0.3
Fraction of presumptive positive on total screens (%)

                                                                                                                                                     12%                                                                             0.25
                                                        2.5%

                                                                                                                                                     10%

                                                                                                                                                                                                              Percent Positive (%)
                                                                                                                                                                                                                                      0.2

                                                                                                                              Percent Positive (%)
                                                        2.0%

                                                                                                                                                     8%
                                                        1.5%                                                                                                                                                                         0.15
                                                                                                                                                     6%
                                                        1.0%                                                                                                                                                                          0.1
                                                                                                                                                     4%

                                                        0.5%                                                                                                                                                                         0.05
                                                                                                                                                     2%

                                                        0.0%                                                                                         0%                                                                                0
                                                            1 Dec 8 Dec 15 Dec 22 Dec 29 Dec 5 Jan 12 Jan 19 Jan                                       1 Dec 8 Dec 15 Dec 22 Dec 29 Dec 5 Jan 12 Jan 19 Jan                             20 Dec    27 Dec     3 Jan   10 Jan    17 Jan        24 Jan
                                                             2021 2021 2021 2021 2021 2022 2022 2022                                                    2021 2021 2021 2021 2021 2022 2022 2022                                          2021      2021      2022     2022      2022          2022

                                                                                                                                                           20-39 years       40-59 years       60-79 years                            All Adult Adm                  Adult Non-COVID-19 Adm
                                                                                                                                                                                                                                      Labour&Delivery Adm            All Pediatric Adm
                                                                                                                                                                                                                                      Pediatric Non-COVID-19 Adm

                                                                                                                                                                                                                                                                                         5
                                                                        Data/Analysis: Creative Destruction Lab-Rapid Screening Consortium (Workplace screening). MCT using OLIS data (repeat testers), Hospital IPAC Teams and Data Analytics (hospital admission screening)
10
                                                                                                             -D
                                                                                                                e

                                                                                                                           30
                                                                                                                                40
                                                                                                                                          50
                                                                                                                                                    60
                                                                                                                                                          70
                                                                                                                                                                    80
                                                                                                                                                                          90
                                                                                                                    c
                                                                                                              7- -20
                                                                                                                 Ja
                                                                                                                    n
                                                                                                             4- -21
                                                                                                                 Fe
                                                                                                                    b
                                                                                                             4- -21
                                                                                                                M
                                                                                                                   ar
                                                                                                              1- -21
                                                                                                                 Ap
                                                                                                            29 r-2
                                                                                                                -A 1
                                                                                                           27 pr- 2
                                                                                                              -M 1
                                                                                                                  a
                                                                                                            24 y-21
                                                                                                                -Ju
                                                                                                                    n
                                                                                                             22 -21
                                                                                                                 -Ju
                                                                                                           19 l-2
                                                                                                               -A 1
                                                                                                                  u
                                                                                                                                                                                    Workplace
                                                                                                            16 g-2
                                                                                                               -S 1
                                                                                                                  e
                                                                                                            14 p-2
                                                                                                                -O 1
                                                                                                           11 ct-2
                                                                                                               -N 1
                                                                                                                  ov
                                                                                                             9- -21
                                                                                                                 De
                                                                                                                    c
                                                                                                              6- -21
                                                                                                                 Ja
                                                                                                                    n-
                                                                                                                      22

                                                                                                           10
                                                                                                                                                                                                  below previous levels.

                                                                                                             -D
                                                                                                                e
                                                                                                                                                                    100
                                                                                                                                                                          110

                                                                                                                           40
                                                                                                                                50
                                                                                                                                     60
                                                                                                                                               70
                                                                                                                                                     80
                                                                                                                                                           90

                                                                                                                    c
                                                                                                              7- -20
                                                                                                                 Ja
                                                                                                                    n
                                                                                                             4- -21
                                                                                                                 Fe
                                                                                                                    b
                                                                                                             4- -21
                                                                                                                M
                                                                                                                   ar
                                                                                                              1- -21
                                                                                                                 Ap
                                                                                                            29 r-2
                                                                                                                -A 1
                                                                                                           27 pr- 2
                                                                                                              -M 1
                                                                                                                  a
                                                                                                            24 y-21
                                                                                                                -Ju
                                                                                                                    n
                                                                                                             22 -21
                                                                                                                 -Ju
                                                                                                           19 l-2
                                                                                                               -A 1
                                                                                                                  u
                                                                                                            16 g-2
                                                                                                               -S 1
                                                                                                                  e
                                                                                                            14 p-2
                                                                                                                                                                           Retail & Recreation

                                                                                                                -O 1
                                                                                                                                                                            Retail & Recreation

                                                                                                           11 ct-2
                                                                                                               -N 1
                                                                                                                  ov
                                                                                                             9- -21
                                                                                                                 De
                                                                                                                    c
                                                                                                              6- -21
                                                                                                                 Ja
                                                                                                                    n-
                                                                                                                      22

                                                                                                           10
                                                                                                             -D
                                                                                                                e
                                                                                                                                                                          100

                                                                                                                           20
                                                                                                                                     40
                                                                                                                                                    60
                                                                                                                                                               80

                                                                                                                    c
                                                                                                              7- -20
                                                                                                                 Ja
                                                                                                                    n
                                                                                                             4- -21
                                                                                                                 Fe
                                                                                                                    b
                                                                                                             4- -21
                                                                                                                M
                                                                                                                   ar
                                                                                                              1- -21
                                                                                                                 Ap
                                                                                                            29 r-2
                                                                                                                -A 1
                                                                                                           27 pr- 2
                                                                                                              -M 1
                                                                                                                  a
                                                                                                            24 y-21
                                                                                                                -Ju
                                                                                                                    n
                                                                                                             22 -21
                                                                                                                 -Ju
                                                                                                           19 l-2
                                                                                                               -A 1
                                                                                                                  u
                                                                                                                                                                                    Transit

                                                                                                            16 g-2
                                                                                                               -S 1
                                                                                                                  e
                                                                                                            14 p-2
                                                                                                                -O 1
                                                                                                           11 ct-2
                                                                                                               -N 1
                                                                                                                  ov
                                                                                                             9- -21
                                                                                                                 De
             Data: https://covid19.apple.com/mobility/ and https://www.google.com/covid19/mobility/
Analysis: Secretariat of the Science Advisory Table (https://covid19-sciencetable.ca/ontario-dashboard/)

                                                                                                                    c
                                                                                                              6- -21
                                                                                                                 Ja
                                                                                                                    n-
                                                                                                                      22
                                                        6
                                                                                                                                                                                                  Mobility, which is correlated with contacts between people, remains
Hospitalizations have increased across all age groups.

                                   New hospital admissions, all ages                                                          New hospital admissions, ≤ 19 years of age
                          250                                                                                                 12

                                                                                                                              10
                          200
New Hospital Admissions

                                                                                                    New Hospital Admissions
                                                                                                                               8
                          150

                                                                                                                               6

                          100
                                                                                                                               4

                           50
                                                                                                                               2

                           0                                                                                                   0
                          1 Dec 2021           15 Dec 2021        29 Dec 2021         12 Jan 2022                             1 Dec 2021     15 Dec 2021         29 Dec 2021          12 Jan 2022

                                ≤ 1 yr   2-5 yrs   6-11 yrs   12-19 yrs   20-59 yrs    ≥ 60 yrs                                            ≤ 1 yr   2-5 yrs   6-11 yrs   12-19 yrs

                                                                                                                                                                                        Data: CCM
                                                                                                                                                                                                     7
                                                                                                                                                                                     Analysis: MCT
COVID inpatient or ICU total census

                     500

                 0
                           1,000
                                   1,500
                                           2,000
                                                   2,500
                                                           3,000
                                                                                                                            3,500
                                                                                                                                                                              4,000
                                                                                                                                                                                          4,500

Aug 26, 20

Sep 16, 20

    Oct 7, 20

Oct 28, 20

Nov 18, 20

    Dec 9, 20

Dec 30, 20

 Jan 20, 21

Feb 10, 21

 Mar 3, 21

Mar 24, 21

Apr 14, 21

 May 5, 21
                                                                                                                                    Patients in ICU with COVID-related critical illness

May 26, 21

Jun 16, 21
                                                               Patients in inpatient beds (incl. ICU) with active COVID19

     Jul 7, 21

 Jul 28, 21

Aug 18, 21

    Sep 8, 21

Sep 29, 21

Oct 20, 21

Nov 10, 21

    Dec 1, 21
                                                                                                                                                                                                  COVID-19-positive hospitalizations are at a pandemic high.

Dec 22, 21

 Jan 12, 22
8
The context for modelling continues to be challenging.
• Population-level case counts have not been reliable since approximately Dec 24, 2021.
  Hence, there is substantial uncertainty on transmissions over the past month given
  decline in testing and high transmissibility of Omicron. This impacts estimates of prior
  infection and degree of immunity.
• We have no clear estimates on the spread of SARS-CoV-2 during previous waves beyond
  identified cases. This impacts estimates of the number of people with prior infection and
  degree of immunity.
• Omicron appears to affect the upper respiratory tract more than the lower respiratory
  tract, and therefore may have a different clinical course than previous variants, which
  may affect hospital and ICU admissions and lengths of stay.
• Hospital and ICU admission data have been used to calibrate the models and to estimate
  the case counts following the change in testing strategy. However, use of hospital and
  ICU data presents challenges:
   • Hospitalizations and ICU use are lagging indicators
   • Limited data on length of stay for patients with Omicron
   • It is difficult to separate hospitalizations for COVID-19 from hospitalizations with COVID-19,
     particularly given ongoing uncertainty on Omicron severity and changing patterns of non-primary
     COVID-19 admissions
• All these factors make it challenging to model the current wave and estimate the impact
  of re-opening.
                                                                                                       9
We expect hospitalizations to rebound after reopening on January 31,
and to remain at a prolonged peak, except under the most favourable
assumptions.
 Figure shows projections based on models
 from two scientific teams.                                                       6000
 • Different models use different                                                        Example scenarios
     approaches and assumptions.
                                                                                              Low community immunity
 • Both models are calibrated to case counts                                                  (2M with recent infection)
     (to mid-December 2021) and hospital
                                                                                              Moderate community immunity
     occupancy (one model), or ICU occupancy

                                                 Hospital occupancy (ward only)
                                                                                              (2.5M with recent infection)
     (one model).                                                                 4000
                                                                                              High community immunity
 • Models assume 8M Ontarians will have                                                       (3M with recent infection)
     received booster dose by end of February.
                                                                                          All example scenarios assume
 • Scenarios differ by level of community                                                 moderate increase in contacts as                                                  Range of
     immunity and changes in contacts as of                                               of January 31, 2022
     January 31, 2022.                                                                                                                                               scenarios considered
 • Considerable uncertainty on current                                            2000

                                                                                                                                                 restrictions lift
                                                                                                                                                 31 Jan: some
     community immunity and changing
     clinical presentation with Omicron.
 • Accelerating uptake of vaccination,
     including boosters, will reduce hospital
     admissions.
 • Expected increased supply of existing                                             0
     therapeutics may reduce hospital                                              Dec 2021                          Jan 2022                    Feb 2022                              Mar 2022

     admissions.

                                                                                                                                Projections informed by modeling from McMasterU, WesternU         10
                                                                                                                                                   Data (hospitalisations): covid-19.ontario.ca
ICU occupancy will likely rebound after reopening on January 31.
Regardless, the pressure on ICUs will be prolonged.
Figure shows projections based on
model from one scientific team.
• Model is calibrated to case
   counts (to mid-December
   2021) and ICU occupancy.                         750

• Range of scenarios shown
   corresponds to example

                                    ICU occupancy
   scenarios in previous slide                                                                      Range of
   (hospitalizations).                                                                         scenarios considered
• Considerable uncertainty due                      500
   to changing clinical
   presentation with Omicron,
   which may result in lower

                                                                           restrictions lift
                                                                           31 Jan: some
   proportion of patients needing
   ICU care compared to Delta.
                                                    250
• Expected increased supply of
   existing therapeutics may
   further reduce ICU admissions.
                                                    Dec 2021   Jan 2022     Feb 2022                               Mar 2022

                                                                          Projections informed by modeling from WesternU       11
                                                                                Data (hospitalisations): covid-19.ontario.ca
Acute care capacity is strained.
                                 Patient Transfers by 7-Day Period Required to                                    Pandemic Period Vented Census Compared to Pre-Pandemic                                                              Hospital Worker Positivity and Isolation Rates
                                 Redistribute Patient Volumes Across Province                                                       (2016-2019) Average
                                                                                                                                                                                                                                30
                                  140                                                                                               1200

                                                                                           Daily ICU Vented Census (CRCI and Non-
                                             ICU to ICU
Number of patients transferred

                                  120                                                                                                                                                                                           25
                                                                          35                                                        1000
                                                                                    6                                                                                                                                                         7-day Rolling
                                  100        Acute ward bed to     20
                                                                                                                                                                                                                                20            average positivity

                                                                                                                                                                                                              Rate per 1,000*
                                             Acute ward bed                        30                                                800                                                                                                      rate
                                   80        Acute to Post-Acute   16     36
                                             Care Facility (ALC)                                                                                                                                                                15            7-day Rolling

                                                                                                           CRCI)*
                                                                                                                                     600                                                                                                      average isolation
                                   60
                                                            7                                                                                                                                                                                 rate (estimated)
                                                                                                                                                                                                                                10
                                   40                      15      76              75                                                400
                                                                          62                                                                         95% Confidence Intervals
                                   20             43                                                                                                                                                                            5
                                                           32                                                                        200             Mean Daily Vented ICU census Pre-COVID (2016--2019)
                                                                                                                                                     7-day Average Total Vented Census (CRCI and non-CRCI)
                                    0      2                                                                                                         7-day Average non-CRCI Vented Census                                       0
                                        Dec 17- Dec 24 Dec 31 Jan 7 to Jan 14     Jan 21                                               0
                                                                                                                                                                                                                                    2 Dec   9 Dec 16 Dec 23 Dec 30 Dec   6 Jan   13 Jan 20 Jan
                                          23    to Dec to Jan 6     13    to 20    to 27                                                                                                                                            2021    2021 2021 2021 2021          2022    2022 2022

                                                                                                                                           20

                                                                                                                                                    20

                                                                                                                                                         20

                                                                                                                                                         20

                                                                                                                                                         20

                                                                                                                                                         20

                                                                                                                                                         20

                                                                                                                                                         20
                                                  30

                                                                                                                                              M

                                                                                                                                                       J

                                                                                                                                                            Se

                                                                                                                                                            De

                                                                                                                                                            M

                                                                                                                                                            Ju

                                                                                                                                                            Se

                                                                                                                                                            De
                                                                                                                                                             un
                                                                                                                                             ar

                                                                                                                                                              ar

                                                                                                                                                              n2
                                                                                                                                                               p2

                                                                                                                                                               p2
                                                                                                                                                               c2

                                                                                                                                                               c2
                                               Week of Transfer Directive

                                                                                                                                                                20
                                                                                                                                                  20

                                                                                                                                                                 20

                                                                                                                                                                 02
                                                                                                                                                                  02

                                                                                                                                                                  02

                                                                                                                                                                  02

                                                                                                                                                                  02
                                                                                                                                                                   20
                                                                                                                                                    20

                                                                                                                                                                    21

                                                                                                                                                                    1
                                                                                                                                                                     0

                                                                                                                                                                     0

                                                                                                                                                                     1

                                                                                                                                                                     1
 Patient transfers have resumed as hospital                                                On January 25, 2022, the total number of patients                                                                          Spread of COVID-19 affects healthcare
 capacity in hardest hit regions becomes                                                   receiving mechanical ventilation was 138% of the                                                                           workers with resulting reduction in staffing.
 threatened. Thus far during wave 5, over                                                  historic average, and the total number of patients in                                                                      * Rate includes hospital workers tested positive, but not those
                                                                                                                                                                                                                      exposed and quarantined, and is therefore an underestimate of
 450 patients with COVID-19 have been                                                      Ontario ICUs was 111% of historic averages.                                                                                staffing challenges. Data do not indicate where infection was
 transferred to prevent hospital resources                                                                                                                                                                            acquired. The vast majority of hospital workers acquire COVID-19
                                                                                           *CRCI: COVID-19 related critical illness
 being overwhelmed.                                                                                                                                                                                                   in the community and not in the hospital setting.

                                                                                                                                                                                                                                                                                                 12
              Data: Ontario Critical Care COVID Command Centre                             Data: CCIS provided courtesy of CCSO                                                                              Data: TAHSN Human Resources Network (test positivity); Analysis: MCT
Vaccination continues to be highly effective against severe outcomes
(hospital and ICU admission).
 Unvaccinated people currently have a 6-fold higher risk of being in the hospital and 12-fold higher risk of
         being in the ICU compared to people who received 2 or 3 doses of a COVID-19 vaccine.

                                                                                       COVID-19 Patients in Hospital                                                                                                                                                       COVID-19 Patients in ICU
                                                  1,200                                                                                                                                                                                   300
    COVID-19 Patients in Hospital per 1 Million Inhabitants

                                                                                                                                                                                     COVID-19 Patients in ICU per 1 Million Inhabitants
                                                  1,000                                                                                                                                                                                   250

                                                                                      Hospital Occupancy Among
                                                              800                           Unvaccinated People                                                                                                                           200

                                                              600                                                                                                                                                                         150                         ICU Occupancy Among
                                                                                                                                                                                                                                                                       Unvaccinated People
                                                              400           Hospital Occupancy Among People                                                                                                                               100

                                                                             Vaccinated with at Least 2 Doses
                                                              200                                                                                                                                                                          50
                                                                                                                                                                                                                                                               ICU Occupancy Among People
                                                                                                                                                                                                                                                              Vaccinated with at Least 2 Doses
                                                                0                                                                                                                                                                           0
                                                                                                                      1

                                                                                                                                                                                                                                                                                                  1
                                                                                            1

                                                                                                              1

                                                                                                                                                                                                                                                                        1

                                                                                                                                                                                                                                                                                          1
                                                                                  1

                                                                                                      1

                                                                                                                                                                                                                                                              1

                                                                                                                                                                                                                                                                                  1
                                                                   1

                                                                            1

                                                                                                                                               1

                                                                                                                                               1

                                                                                                                                                                                                                                               1

                                                                                                                                                                                                                                                        1

                                                                                                                                                                                                                                                                                                                         1

                                                                                                                                                                                                                                                                                                                         1
                                                                                                                                              22

                                                                                                                                              22

                                                                                                                                                                                                                                                                                                                       22

                                                                                                                                                                                                                                                                                                                       22
                                                                                                                              1

                                                                                                                                      1

                                                                                                                                                                                                                                                                                                          1

                                                                                                                                                                                                                                                                                                                        1
                                                                                                                    -2

                                                                                                                                                                                                                                                                                                -2
                                                                                          -2

                                                                                                            -2

                                                                                                                                                                                                                                                                      -2

                                                                                                                                                                                                                                                                                        -2
                                                                                -2

                                                                                                                                                                                                                                                            -2
                                                                 -2

                                                                          -2

                                                                                                                                             -2

                                                                                                                                             -2

                                                                                                                                                                                                                                             -2

                                                                                                                                                                                                                                                      -2

                                                                                                                                                                                                                                                                                                                      -2

                                                                                                                                                                                                                                                                                                                      -2
                                                                                                                            -2

                                                                                                                                    -2

                                                                                                                                                                                                                                                                                                        -2

                                                                                                                                                                                                                                                                                                                      -2
                                                                                                   -2

                                                                                                                                                                                                                                                                               -2
                                                                                                                                            n-

                                                                                                                                            n-

                                                                                                                                                                                                                                                                                                                     n-

                                                                                                                                                                                                                                                                                                                     n-
                                                                                                                  ov

                                                                                                                                                                                                                                                                                              ov
                                                                                          ep

                                                                                                                                                                                                                                                                      ep
                                                              ug

                                                                       ug

                                                                                                                                                                                                                                          ug

                                                                                                                                                                                                                                                   ug
                                                                                                          ct

                                                                                                                                                                                                                                                                                      ct
                                                                                  p

                                                                                                                                                                                                                                                              p
                                                                                                 ct

                                                                                                                                                                                                                                                                             ct
                                                                                                                                           ec

                                                                                                                                           ec

                                                                                                                                                                                                                                                                                                                    ec

                                                                                                                                                                                                                                                                                                                    ec
                                                                                                                          ov

                                                                                                                                  ov

                                                                                                                                                                                                                                                                                                      ov

                                                                                                                                                                                                                                                                                                                    ov
                                                                                                                                        - Ja

                                                                                                                                        - Ja

                                                                                                                                                                                                                                                                                                                 - Ja

                                                                                                                                                                                                                                                                                                                 - Ja
                                                                               Se

                                                                                                                                                                                                                                                           Se
                                                                                                        -O

                                                                                                                                                                                                                                                                                    -O
                                                                                                  O

                                                                                                                                                                                                                                                                              O
                                                                                                                 N

                                                                                                                                                                                                                                                                                             N
                                                                                                                                       -D

                                                                                                                                       -D

                                                                                                                                                                                                                                                                                                                -D

                                                                                                                                                                                                                                                                                                                -D
                                  -A

                                                                      -A

                                                                                                                                                                                                        -A

                                                                                                                                                                                                                                                  -A
                                                                                        -S

                                                                                                                                                                                                                                                                    -S
                                                                                                                       -N

                                                                                                                               -N

                                                                                                                                                                                                                                                                                                    -N

                                                                                                                                                                                                                                                                                                           -N
                                                                            7-

                                                                                               5-

                                                                                                                                                                                                                                                        7-

                                                                                                                                                                                                                                                                           5-
                                                                                                              2-

                                                                                                                                                                                                                                                                                          2-
                                                                                                                                     11

                                                                                                                                     25

                                                                                                                                                                                                                                                                                                              11

                                                                                                                                                                                                                                                                                                              25
                                                                                      21

                                                                                                      19

                                                                                                                                                                                                                                                                  21

                                                                                                                                                                                                                                                                                  19
                                10

                                                                    24

                                                                                                                                     14

                                                                                                                                     28

                                                                                                                                                                                                      10

                                                                                                                                                                                                                                                24

                                                                                                                                                                                                                                                                                                              14

                                                                                                                                                                                                                                                                                                              28
                                                                                                                     16

                                                                                                                             30

                                                                                                                                                                                                                                                                                                  16

                                                                                                                                                                                                                                                                                                         30
                                                                                                                     Date                                                                                                                                                                        Date

                                                                                                                                                                            Analysis: Secretariat of the Science Advisory Table (https://covid19-sciencetable.ca/ontario-dashboard/)                                         13
                                                                                                                                          Data: https://data.ontario.ca/ and CCM plus; estimates of patients in hospital and ICU are age standardized, see dashboard for explanation
New vaccine effectiveness data from Ontario shows strong protection
against severe outcomes with vaccination and the importance of
boosters.

                                                                                                                    14
                                     Source: ICES (https://www.medrxiv.org/content/10.1101/2021.12.30.21268565v2)
Vaccine coverage with 3rd doses in adults and with 1st and 2nd doses
                                                   has increased, but is slowing down in all age groups.

                                                             Number of Vaccinated Individuals & Doses Administered                                                                                                                        Percentage Vaccinated, by Age
                                                                                                                     250,000

                                                                                                                               Daily Number of Vaccine Doses Administered (7-Day Average)
                                                                                                                                                                                                              80+         3 Doses
                                              12,000,000   1 Dose
                                                                                                                                                                                                                          2 Doses
Cumulative Number of Vaccinated Individuals

                                                           2 Doses                                                                                                                                           70-79
                                                                                                                     200,000                                                                                              1 Dose
                                              10,000,000   3 Doses
                                                                                                                                                                                                             60-69
                                                           Doses per Day
                                               8,000,000                                                             150,000
                                                                                                                                                                                                             50-59

                                                                                                                                                                                               Age (Years)
                                                                                                                                                                                                             40-49
                                               6,000,000
                                                                                                                     100,000                                                                                 30-39
                                               4,000,000
                                                                                                                                                                                                             18-29
                                                                                                                     50,000
                                               2,000,000                                                                                                                                                     12-17

                                                                                                                                                                                                              5-11
                                                      0                                                              0
                                                                                                                                                                                                                     0%       10%   20%   30%      40%      50%     60%       70%       80%       90%   100%
                                                                  1

                                                                21
                                                                  1

                                                                  1
                                                                21

                                                                  1
                                                                21

                                                                22
                                                                  1

                                                                  1
                                                                  1

                                                                  1
                                                                21

                                                                 1
                                                                 0

                                                               02

                                                               02
                                                              02
                                                               02

                                                               02

                                                               02
                                                               02

                                                               02
                                                               02
                                                               02

                                                             20
                                                             20
                                                             20
                                                             20

                                                             20
                                                            -2
                                                            -2

                                                            -2

                                                            -2
                                                            -2

                                                            -2
                                                          r-2
                                                            -2

                                                            -2
                                                           l-2
                                                          b-

                                                          c-
                                                          n-
                                                          n-

                                                          n-
                                                         ov
                                                        ep
                                                        ug
                                                         pr

                                                        ay
                                                         ar

                                                         ct
                                                        ec

                                                      - Ju

                                                                                                                                                                                                                                                Percentage Vaccinated
                                                      Ap

                                                      De
                                                     - Ju
                                                      Ja

                                                      Ja
                                                      Fe

                                                    -O
                                                     M

                                                    -A

                                                    -N
                                                   -M
                                                    -D

                                                    -A

                                                    -S
                                                  7-

                                                  6-
                                                  22
                                                  4-

                                                  1-

                                                  9-
                                                 24
                                                 4-

                                                 29

                                                 16

                                                 14
                                                10

                                                19

                                                11
                                                27

                                                                                       Date

                                                                                                                                                                                                                                                                        Data: https://data.ontario.ca   15
                                                                                                                                                                                            Analysis: Secretariat of the Science Advisory Table (https://covid19-sciencetable.ca/ontario-dashboard/)
Key findings
• It is challenging to model the spread of COVID-19 because of changes
  in testing, but other indicators suggest this phase of the Omicron wave
  has plateaued or is in decline.
• Public health measures helped control this phase. Relaxation of these
  measures will increase the spread of COVID-19. The size of any
  resurgence is difficult to predict and will depend on vaccination, the
  spread of Omicron, and changes in behaviour (e.g., mobility, masking).
• Surveillance will be important to detect changes in the trajectory of the
  pandemic.
• Hospitals are now caring for the highest number of people with COVID-
  19. Admissions are at highest levels across all age groups. ICU
  occupancy continues to be high. Staffing in hospitals remains critical.
• Ontario data shows that vaccination (including third doses) provides
  strong protection against serious illness. Increasing vaccine uptake
  across all groups will reduce the impact of the pandemic.
                                                                              16
Contributors
• Creative Destruction Lab-Rapid Screening Consortium
• Hospital Infection Prevention And Control (IPAC) Teams and Data Analytics: Suhair AlShanteer, Michelle Barton
  Forbes, Steven Bernard, Craig Campbell, Michael Chow, Robert Crawford, Gerald Evans, Jayvee Guerrero, Kevin
  Katz, Erin Kelleher, Sarah Khan, Ethel Lagman, Melanie Lavigne, Kirk Leifso, Sheri Levesque, Reena Lovinsky, Tracy
  Macleod, Jennifer McCallum, Dominik Mertz, Vydia Nankoosingh, Kasey Parker, Paul Sandor, Michelle Science,
  Shawna Silver, Celia So, Rachel Solomon, Nisha Thampi, Alon Vaisman, Elisa Vicencio, Eugene Wong
• ICES: Sarah Buchan, Hannah Chung, Kevin Brown, Peter Austin, Deshayne Fell, Jonathan Gubbay, Sharifa Nasreen,
  Kevin Schwartz, Maria Sundaram, Mina Tadrous, Kumanan Wilson, Sarah Wilson, Jeff Kwong
• McMasterU: Irena Papst, Ben Bolker, Jonathan Dushoff, David Earn
• Modeling Consensus Table: Kali Barrett, Isha Berry, Sharmistha Mishra, Ashleigh Tuite, Beate Sander
• Ontario Health: Erik Hellsten, Stephen Petersen, Anna Lambrinos
• Science Advisory Table: Peter Jüni, Nicolas Bodmer, Karen Born, Shujun Yan
• TAHSN Human Resources Network: Sunnybrook Health Sciences Centre, North York General Hospital, Trillium
  Health Partners, Women’s College Hospital, Hospital for Sick Children, Unity Health Network, Humber River
  Regional Hospital, Scarborough Health Network
• Western University/London Health Sciences Centre: Lauren Cipriano, Wael Haddara
• St. Michael’s Hospital/University of Toronto: Bruno R. da Costa                                                  17
Content and review by Modelling Consensus and Scientific Advisory
Table members and secretariat
Beate Sander,* Peter Jüni, Brian Schwartz,* Upton Allen, Vanessa Allen, Kali Barrett, Isha Berry,
Nicolas Bodmer, Isaac Bogoch, Karen Born, Kevin Brown, Sarah Buchan, Swetaprovo Chaudhuri,
Yoojin Choi, Lauren Cipriano, Troy Day, David Earn,* Gerald Evans, Jennifer Gibson, Anne Hayes,*
Michael Hillmer, Jessica Hopkins, Jeff Kwong, Fiona Kouyoumdjian, Audrey Laporte, John Lavis,
Gerald Lebovic, Brian Lewis, Stephanie Lockert, Linda Mah, Kamil Malikov, Doug Manuel, Roisin
McElroy, Allison McGeer, Michelle Murti, John McLaughlin, Sharmistha Mishra, Andrew Morris,
Samira Mubareka, Christopher Mushquash, Ayodele Odutayo, Menaka Pai, Alyssa Parpia, Samir
Patel, Anna Perkhun, Bill Praamsma, Justin Presseau, Fahad Razak, Rob Reid, Paula Rochon, Laura
Rosella, Michael Schull, Arjumand Siddiqi, Chris Simpson, Arthur Slutsky, Janet Smylie, Robert
Steiner, Ashleigh Tuite, Tania Watts, Ashini Weerasinghe, Scott Weese, Xiaolin Wei, Jianhong Wu,
Diana Yan, Emre Yurga

*Chairs of Scientific Advisory, Evidence Synthesis, and Modelling Consensus Tables
For table membership and profiles, please visit the About and Partners pages on the Science
Advisory Table website.
                                                                                                    18
You can also read